| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgements
|
|
|
|
27 |
S5 |
p. v_vi
|
artikel
|
| 2 |
Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
|
Hoelzer, D.
|
|
|
27 |
S5 |
p. v69-v82
|
artikel
|
| 3 |
appendix 6: Chronic lymphocytic leukaemia: eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Haematological-Malignancies)
|
Eichhorst, B.
|
|
|
27 |
S5 |
p. v143-v144
|
artikel
|
| 4 |
appendix 2: Cutaneous melanoma (2): eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Melanoma)
|
Dummer, R.
|
|
|
27 |
S5 |
p. v136-v137
|
artikel
|
| 5 |
appendix 1: Cutaneous melanoma (1): eUpdate published online September 2016 (www.esmo.org/Guidelines/Melanoma)
|
|
|
|
27 |
S5 |
p. v134-v135
|
artikel
|
| 6 |
appendix 5: Metastatic colorectal cancer (2): eUpdate published online August 2016 (www.esmo.org/Guidelines/Gastrointestinal-Cancers)
|
|
|
|
27 |
S5 |
p. v142
|
artikel
|
| 7 |
appendix 4: Metastatic colorectal cancer (1): eUpdate published online September 2016 (www.esmo.org/Guidelines/Gastrointestinal-Cancers)
|
|
|
|
27 |
S5 |
p. v140-v141
|
artikel
|
| 8 |
appendix 3: Neuroendocrine tumours: eUpdate published online September 2016 (www.esmo.org/Guidelines/Neuroendocrine-Tumours)
|
|
|
|
27 |
S5 |
p. v138-v139
|
artikel
|
| 9 |
appendix 7: Ovarian cancer: eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Gynaecological-Malignancies)
|
Ledermann, J.A.
|
|
|
27 |
S5 |
p. v145
|
artikel
|
| 10 |
appendix 8: Prostate cancer: eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Genitourinary-Cancers)
|
Parker, C.
|
|
|
27 |
S5 |
p. v146-v147
|
artikel
|
| 11 |
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
|
Valle, J.W.
|
|
|
27 |
S5 |
p. v28-v37
|
artikel
|
| 12 |
Editorial board
|
|
|
|
27 |
S5 |
p. ii-iii
|
artikel
|
| 13 |
ESMO Guidelines Committee
|
|
|
|
27 |
S5 |
p. v_v
|
artikel
|
| 14 |
ESMO Guidelines Committee Disclosures
|
|
|
|
27 |
S5 |
p. v149-v150
|
artikel
|
| 15 |
Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
|
Vitolo, U.
|
|
|
27 |
S5 |
p. v91-v102
|
artikel
|
| 16 |
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up †
|
Smyth, E.C.
|
|
|
27 |
S5 |
p. v38-v49
|
artikel
|
| 17 |
Management of febrile neutropaenia: ESMO Clinical Practice Guidelines†
|
Klastersky, J.
|
|
|
27 |
S5 |
p. v111-v118
|
artikel
|
| 18 |
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
|
Roila, F.
|
|
|
27 |
S5 |
p. v119-v133
|
artikel
|
| 19 |
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
|
Novello, S.
|
|
|
27 |
S5 |
p. v1-v27
|
artikel
|
| 20 |
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up †
|
Dreyling, M.
|
|
|
27 |
S5 |
p. v83-v90
|
artikel
|
| 21 |
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up †
|
Lordick, F.
|
|
|
27 |
S5 |
p. v50-v57
|
artikel
|
| 22 |
Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening †
|
Paluch-Shimon, S.
|
|
|
27 |
S5 |
p. v103-v110
|
artikel
|
| 23 |
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up †
|
Escudier, B.
|
|
|
27 |
S5 |
p. v58-v68
|
artikel
|
| 24 |
Table of Contents
|
|
|
|
27 |
S5 |
p. iv
|
artikel
|
| 25 |
The ESMO Guidelines Committee would like to publish the following corrections to manuscripts published in 2015
|
|
|
|
27 |
S5 |
p. v148
|
artikel
|
Tijdschrift beschrijving